CollPlant Biotechnologies Ltd - ADR

NASDAQ:CLGN  
13.65
-0.25 (-1.80%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)94.03M
Current PEN/A
Forward PE 13.51
2yr Forward PE 9.61
See more stats
Estimates Current Quarter
Revenue$10.06 Million
Adjusted EPS$0.50
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

CollPlant Biotechnologies Ltd - ADR Stock, NASDAQ:CLGN

Weizmann Science Park, 4 Oppenheimer Street, Rehovot, Tel Aviv 7670104
Israel
Phone: +972.73.232.5600
Number of Employees: 52

Description

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. It's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.